We conclude that miR-203 inhibits lung metastasis, not by triggering differentiation, but by directly targeting the prometastatic genes LASP1, SPARC, and NUAK1, which are prognostic factors in human HNSCC. The gene discussed is NUAK1; the disease is head and neck squamous cell carcinoma.